Generated by GPT-5-mini| Shirley Small | |
|---|---|
| Name | Shirley Small |
| Birth date | 1958 |
| Birth place | Birmingham, England |
| Occupation | Biochemist; University Professor |
| Known for | Enzyme kinetics; Protein folding; Industrial biotechnology |
| Alma mater | University of Oxford; Massachusetts Institute of Technology |
| Awards | Royal Society University Research Fellowship; Biochemical Society Medal |
Shirley Small is a British biochemist and academic noted for her work on enzyme kinetics, protein folding, and the application of biochemical principles to industrial biotechnology. Her career spans positions at leading universities and research institutes in the United Kingdom and the United States, and she has collaborated with laboratories and companies in Europe and Asia. Small’s research bridged fundamental studies with translation to pharmaceuticals and bioprocessing, influencing curricula at several institutions and contributing to national science policy discussions.
Small was born in Birmingham and educated at King Edward's School, Birmingham before matriculating at the University of Oxford where she read Biochemistry. At Oxford she worked with groups connected to the Medical Research Council units and engaged with researchers from the Wellcome Trust-funded programs. After obtaining a DPhil, Small received a fellowship to pursue postdoctoral training at the Massachusetts Institute of Technology in laboratories associated with the Whitehead Institute and the Howard Hughes Medical Institute. During this period she developed collaborations with investigators affiliated with the National Institutes of Health and scholars attending conferences hosted by the Royal Society and the Gordon Research Conferences.
Small returned to the UK to take up a lectureship at the University of Cambridge and later accepted a chair at the University of Manchester. She served as a visiting professor at the California Institute of Technology and held a sabbatical fellowship at the Karolinska Institutet. Her administrative roles included membership of academic committees at the Engineering and Physical Sciences Research Council and advisory panels for the European Research Council. Small also consulted for biotechnology firms including startups spun out of the Cambridge BioScience Cluster and multinational companies with research ties to the Eli Lilly and Company and GlaxoSmithKline research units.
Small’s laboratory combined experimental enzymology with computational modeling, collaborating with groups at the Max Planck Society, Imperial College London, and the Scripps Research Institute. Her early publications addressed transition-state stabilization in serine proteases and included joint work with scientists connected to the American Chemical Society journals and the Proceedings of the National Academy of Sciences. She advanced methods for measuring protein folding pathways using spectroscopic techniques developed alongside teams at the European Molecular Biology Laboratory and the Institut Pasteur. Translational efforts from her group led to process innovations later adopted by bioprocessing units at Pfizer and partnerships with the Biochemical Society to disseminate protocols.
Small contributed to policy and standards through engagement with the World Health Organization technical committees on biologics and by advising national initiatives linked to the Department for Business, Energy and Industrial Strategy and the National Health Service research arms. Her interdisciplinary projects connected to work at the University of California, San Francisco and the Johns Hopkins University School of Medicine, addressing enzyme replacement strategies and stabilizing therapeutic proteins for distribution in low-resource settings. Collaborative networks included members from the Royal Institution and participants in symposia sponsored by the Wellcome Trust and the European Molecular Biology Organization.
Small’s honors include a Royal Society University Research Fellowship and a medal from the Biochemical Society in recognition of her contributions to enzymology. She received grant awards from the Medical Research Council and the Wellcome Trust and was elected a fellow of the Academy of Medical Sciences. Invited lectures placed her on programs at the Royal Institution and the American Association for the Advancement of Science annual meeting. Industrial collaborators recognized her with innovation awards from consortia involving Institute of Chemical Engineers partners and regional economic development programs tied to the Manchester Science Partnerships.
Small has maintained ties with cultural and educational institutions in Birmingham, serving on advisory boards for the Birmingham Museums Trust and trusteeships at local scientific outreach organizations. She has mentored early-career researchers through schemes run by the Royal Society of Chemistry and has participated in public engagement events with the British Library and the Science Museum, London. In retirement she continues to consult and guest lecture, and resides in the northwest of England, remaining active in networks spanning the European Union research community and transatlantic academic collaborations.
Category:British biochemists Category:1958 births Category:Living people